Growth of 30% was observed in Uzbekistan's pharmaceutical production.
According to data from the State Statistics Committee, in January–April 2026, large enterprises in Uzbekistan produced pharmaceutical products and preparations worth approximately 1.9 trillion soums. This was reported by Zamin.uz.
This indicator shows a significant growth of 30% compared to the same period last year. In regional terms, production volume There is a sharp disparity among regions in the production of medicines and medical products in our country.
The main production capacities are concentrated in the capital and its surrounding areas. Tashkent City, with output of 1.2 trillion soums, accounts for nearly 63% of the republic's total volume.
Sirdaryo Region ranks second with 261.5 billion soums. Tashkent Region follows with an indicator of 123.5 billion soums.
Namangan Region contributed 106.2 billion soums, Samarqand Region 78.4 billion soums, Fergana Region 40.3 billion soums, Andijan Region 39.9 billion soums, Surkhandarya Region 30.3 billion soums, Kashkadarya Region 7.8 billion soums, and Bukhara Region 4.7 billion soums. Key drivers Tashkent City maintains absolute leadership in the pharmaceutical industry.
Nearly 63% of the total products manufactured in the republic fall under the capital's share. Moreover, Sirdaryo and Tashkent Regions also hold strong positions as major pharmaceutical clusters.
These three regions together form the core strength of the republic's pharmaceutical industry. It should be emphasized that the stability of growth rates in the pharmaceutical sector positively impacts the strengthening of the country's healthcare system.
The increase in medicine production volumes enhances the supply of the domestic market.
